ARIH1 and neoplasm: In contrast to ARIH1 silenced cells, xenograft injection of control and ARIH1 ORF SUM159 cells resulted in no significant change in tumor burden between groups (Supplementary Fig. S3f–h), consistent with our mammosphere assays performed in vitro (Fig. 4b, c, Supplementary Fig. S3d).